Gene · 8900
Papers2,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling by LncRNAs: Structure, Cellular Homeostasis, and Disease Pathology. | Cells | 2022 | 36010595 | PubTator, text mining | PubMed |
| Chromosome Translocations, Gene Fusions, and Their Molecular Consequences in Pleomorphic Salivary Gland Adenomas. | Biomedicines | 2022 | 36009517 | PubTator, text mining | PubMed |
| Effects and Mechanisms of Curcumin for the Prevention and Management of Cancers: An Updated Review. | Antioxidants (Basel) | 2022 | 36009200 | PubTator, text mining | PubMed |
| Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface. | Elife | 2022 | 35975985 | PubTator, text mining | PubMed |
| Utility of serum and salivary lactate dehydrogenase and uric acid levels as a diagnostic profile in oral squamous cell carcinoma patients. | J Oral Maxillofac Pathol | 2022 | 35968187 | PubTator, text mining | PubMed |
| The Correlation Between MicroRNAs and Diabetic Retinopathy. | Front Immunol | 2022 | 35958584 | PubTator, text mining | PubMed |
| Both a hypoxia-inducible EYA3 and a histone acetyltransferase p300 function as coactivators of SIX5 to mediate tumorigenesis and cancer progression. | Ann Transl Med | 2022 | 35957720 | PubTator, text mining | PubMed |
| Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy. | Cancers (Basel) | 2022 | 35954407 | PubTator, text mining | PubMed |
| Hexokinase 2 promoted cell motility and proliferation by activating Akt1/p-Akt1 in human ovarian cancer cells. | J Ovarian Res | 2022 | 35953860 | PubTator, text mining | PubMed |
| LAP3 contributes to IFN-γ-induced arginine depletion and malignant transformation of bovine mammary epithelial cells. | BMC Cancer | 2022 | 35941558 | PubTator, text mining | PubMed |
| Cytokine Activation Reveals Tissue-Imprinted Gene Profiles of Mesenchymal Stromal Cells. | Front Immunol | 2022 | 35924240 | PubTator, text mining | PubMed |
| Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment. | Cell Mol Biol Lett | 2022 | 35922753 | PubTator, text mining | PubMed |
| Downstream Neighbor of Son Overexpression is Associated With Breast Cancer Progression and a Poor Prognosis. | J Breast Cancer | 2022 | 35914745 | PubTator, text mining | PubMed |
| Mechanisms of long non-coding RNAs in biological phenotypes and ferroptosis of glioma. | Front Oncol | 2022 | 35912271 | PubTator, text mining | PubMed |
| An Overview of the Biological Evaluation of Selected Nitrogen-Containing Heterocycle Medicinal Chemistry Compounds. | Int J Mol Sci | 2022 | 35897691 | PubTator, text mining | PubMed |
| Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling. | Int J Mol Sci | 2022 | 35887076 | PubTator, text mining | PubMed |
| Present Status, Challenges, and Prospects of Dihydromyricetin in the Battle against Cancer. | Cancers (Basel) | 2022 | 35884547 | PubTator, text mining | PubMed |
| DNA methylation-mediated differential expression of DLX4 isoforms has opposing roles in leukemogenesis. | Cell Mol Biol Lett | 2022 | 35883028 | PubTator, text mining | PubMed |
| Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia. | Sci Rep | 2022 | 35859008 | PubTator, text mining | PubMed |
| Fibroblast growth factor 10 protects against UVB-induced skin injury by activating the ERK/YAP signalling pathway. | Cell Prolif | 2022 | 35851701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8900/papers?page=16